論文- 佐藤 公雄 -
表示方法: 表示形式: 表示順:
件数:141件
[2013]
101.Combination therapy with atorvastatin and amlodipine suppresses angiotensin II-induced aortic aneurysm formation..[PloS one,8(8),(2013),e72558-]Takahashi K, Matsumoto Y, Do e Z, Kanazawa M, Satoh K, Shimizu T, Sato A, Fukumoto Y, Shimokawa H
10.1371/journal.pone.0072558
http://www.ncbi.nlm.nih.gov/pubmed/23967318
102.Linoleic acid. A novel mechanism of endothelial cell dysfunction..[Circ J,77(11),(2013),2702-2703]Satoh, Kimio
http://www.ncbi.nlm.nih.gov/pubmed/24077059
103.Dipeptidyl peptidase-4 inhibitors--emerging player for vascular protection..[Circulation Journal,77(5),(2013),1156-1157]Satoh K
10.1253/circj.CJ-13-0064
http://www.ncbi.nlm.nih.gov/pubmed/23386273
104.Plasma cyclophilin A is a novel biomarker for coronary artery disease..[Circulation Journal,77(2),(2013),447-455]Satoh K, Fukumoto Y, Sugimura K, Miura Y, Aoki T, Nochioka K, Tatebe S, Miyamichi-Yamamoto S, Shimizu T, Osaki S, Takagi Y, Tsuburaya R, Ito Y, Matsumoto Y, Nakayama M, Takeda M, Takahashi J, Ito K, Yasuda S, Shimokawa H
10.1253/circj.CJ-12-0805
http://www.ncbi.nlm.nih.gov/pubmed/23138189
[2012]
105.脳死片肺移植後全身感染症にて死亡し、剖検にて血球貪食症候群が明らかとなった1例.[日本病理学会会誌,101(2),(2012),63]齊藤 涼子, 藤島, 史喜, 深谷, 佐智子, 佐藤, 聡子, 柴原, 裕紀子, 谷内, 真司, 笠島, 敦子, 中村, 保宏, 石田, 和之, 渡辺, みか, 笹野 公伸
106.末梢性脱髄疾患で発症し、筋萎縮性側索硬化症を合併した1剖検例.[日本病理学会会誌,101(2),(2012),65]深谷 佐智子, 藤島, 史喜, 齊藤, 涼子, 佐藤, 聡子, 柴原, 裕紀子, 谷内, 真司, 笠島, 敦子, 中村, 保宏, 渡辺 みか, 北本, 哲之, 笹野 公伸
107.剖検により診断された血管内大細胞型B細胞リンパ腫(IVL)の1例.[日本病理学会会誌,101(2),(2012),65]佐藤 聡子, 深谷, 佐智子, 佐藤, 直実, 谷内, 真司, 柴原, 裕紀子, 笠島, 敦子, 中村, 保宏, 藤島, 史喜, 渡辺 みか, 一迫, 玲, 笹野 公伸
108.Current Perspectives on Protective Roles of Erythropoietin in Cardiovascular System: Erythropoietin Receptor as a Novel Therapeutic Target.[TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE,227(2),(2012),83-91]Yutaka Kagaya, Yasuhide Asaumi, Wanting Wang, Morihiko Takeda, Makoto Nakano, Kimio Satoh, Yoshihiro Fukumoto, Hiroaki Shimokawa
10.1620/tjem.227.83
http://www.ncbi.nlm.nih.gov/pubmed/22688525 http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000305547400001&DestApp=WOS
109.Clinical Significance of Reactive Post-Capillary Pulmonary Hypertension in Patients With Left Heart Disease.[CIRCULATION JOURNAL,76(5),(2012),1235-1244]Shunsuke Tatebe, Yoshihiro Fukumoto, Koichiro Sugimura, Saori Miyamichi-Yamamoto, Tatsuo Aoki, Yutaka Miura, Kotaro Nochioka, Kimio Satoh, Hiroaki Shimokawa
10.1253/circj.CJ-11-1288
http://www.ncbi.nlm.nih.gov/pubmed/22313804 http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000303369800029&DestApp=WOS
110.Basiliximabを用いた心臓移植5例の検討.[移植,47(1),(2012),104-105]早津 幸弘, 秋山 正年, 松尾 諭志, 伊藤 校輝, 鈴木 佑輔, 佐藤 充, 佐藤 真一, 渋谷 拓見, 増田 信也, 斎藤 武志, 安達 理, 熊谷 紀一郎, 本吉 直孝, 秋葉 美紀, 川本 俊輔, 齋木 佳克
111.Percutaneous Transluminal Pulmonary Angioplasty Markedly Improves Pulmonary Hemodynamics and Long-Term Prognosis in Patients With Chronic Thromboembolic Pulmonary Hypertension.[CIRCULATION JOURNAL,76(2),(2012),485-488]Koichiro Sugimura, Yoshihiro Fukumoto, Kimio Satoh, Kotaro Nochioka Md, Yutaka Miura, Tatsuo Aoki, Shunsuke Tatebe, Saori Miyamichi-Yamamoto, Hiroaki Shimokawa
10.1253/circj.CJ-11-1217
http://www.ncbi.nlm.nih.gov/pubmed/22185711 http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000299666300038&DestApp=WOS
112.Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension..[Circ J,76(2),(2012),485-488]Sugimura, Koichiro Fukumoto, Yoshihiro Satoh, Kimio Nochioka, Kotaro Miura, Yutaka Aoki, Tatsuo Tatebe, Shunsuke Miyamichi-Yamamoto, Saori Shimokawa, Hiroaki
http://www.ncbi.nlm.nih.gov/pubmed/22185711
113.Clinical significance of reactive post-capillary pulmonary hypertension in patients with left heart disease..[Circ J,76(5),(2012),1235-1244]Tatebe, Shunsuke Fukumoto, Yoshihiro Sugimura, Koichiro Miyamichi-Yamamoto, Saori Aoki, Tatsuo Miura, Yutaka Nochioka, Kotaro Satoh, Kimio Shimokawa, Hiroaki
http://www.ncbi.nlm.nih.gov/pubmed/22313804
114.Current perspectives on protective roles of erythropoietin in cardiovascular system: erythropoietin receptor as a novel therapeutic target..[Tohoku J Exp Med,227(2),(2012),83-91]Kagaya, Yutaka Asaumi, Yasuhide Wang, Wanting Takeda, Morihiko Nakano, Makoto Satoh, Kimio Fukumoto, Yoshihiro Shimokawa, Hiroaki
http://www.ncbi.nlm.nih.gov/pubmed/22688525
[2011]
115.Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension..[BMC immunology,12,(2011),67-]Rabieyousefi M, Soroosh P, Satoh K, Date F, Ishii N, Yamashita M, Oka M, McMurtry IF, Shimokawa H, Nose M, Sugamura K, Ono M
10.1186/1471-2172-12-67
http://www.ncbi.nlm.nih.gov/pubmed/22171643
116.Emergence of the erythropoietin/erythropoietin receptor system as a novel cardiovascular therapeutic target..[Journal of Cardiovascular Pharmacology,58(6),(2011),570-574]Satoh K, Fukumoto Y, Nakano M, Kagaya Y, Shimokawa H
10.1097/FJC.0b013e318235e7bb
http://www.ncbi.nlm.nih.gov/pubmed/21934628
117.Prognostic Impact of Myocardial Interstitial Fibrosis in Non-Ischemic Heart Failure - Comparison Between Preserved and Reduced Ejection Fraction Heart Failure.[CIRCULATION JOURNAL,75(11),(2011),2605-2613]Tatsuo Aoki, Yoshihiro Fukumoto, Koichiro Sugimura, Minako Oikawa, Kimio Satoh, Makoto Nakano, Masaharu Nakayama, Hiroaki Shimokawa
10.1253/circj.CJ-11-0568
http://www.ncbi.nlm.nih.gov/pubmed/21821961 http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000296403100017&DestApp=WOS
118.Intensive Immunosuppressive Therapy Improves Pulmonary Hemodynamics and Long-Term Prognosis in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.[CIRCULATION JOURNAL,75(11),(2011),2668-2674]Saori Miyamichi-Yamamoto, Yoshihiro Fukumoto, Koichiro Sugimura, Tomonori Ishii, Kimio Satoh, Yutaka Miura, Shunsuke Tatebe, Kotaro Nochioka, Tatsuo Aoki, Zhulanqiqige Doe, Hiroaki Shimokawa
10.1253/circj.CJ-11-0473
http://www.ncbi.nlm.nih.gov/pubmed/21873802 http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000296403100026&DestApp=WOS
119.Rho-kinase: important new therapeutic target in cardiovascular diseases..[American Journal of Physiology. Heart and Circulatory Physiology,301(2),(2011),H287-96]Satoh K, Fukumoto Y, Shimokawa H
10.1152/ajpheart.00327.2011
http://www.ncbi.nlm.nih.gov/pubmed/21622831
120.Vascular-derived reactive oxygen species for homeostasis and diseases..[Nitric Oxide,25(2),(2011),211-215]Satoh K, Berk BC, Shimokawa H
10.1016/j.niox.2011.04.005
http://www.ncbi.nlm.nih.gov/pubmed/21565278
Page: [prev] [1] [2] [3] [4] [5] [6] [7] [8] [next]
戻るこのページのトップへ
copyright(c)2005 Tohoku University